N - CARDIOMETABOLIC

Clinicians should evaluate all adults with SCI for cardiometabolic disease at the time of rehabilitation discharge. For those already discharged from rehabilitation, evaluate for cardiometabolic disease at the earliest opportunity and at three-year intervals. (Adapted from NASH 2018, p.402; Level C)

Clinicians are recommended to use the American Heart Association (AHA) definition and the five constituent hazards of obesity, insulin resistance, dyslipidemia (including individual risks of low high-density lipoprotein cholesterol (HDL-C) and elevated triglycerides (TG), and hypertension)), as cardiometabolic disease risk components for individuals with SCI. (Adapted from NASH 2018, p.402; Level C)